Skip to main
CVSA

CVSA Stock Forecast & Price Target

CVSA Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Covista is a financially sound company with a positive outlook due to its diverse portfolio of universities, strong performance, and expansion plans. Despite potential challenges, such as a slowdown in enrollment and regulatory issues, the company's executive appointments and compensation structure suggest a confident outlook for the future.

Bears say

Covista is facing several challenges, including execution issues and uncertainty around the Chamberlain segment, increased regulatory scrutiny from the Department of Education, and a potential decrease in demand for college education. With a focus on labor shortages and upskilling trends, Covista's clinical healthcare-focused institutions may not be able to attract enough students to sustain its growth, especially with the availability of alternative options for higher education. Additionally, the company's exposure to new loan caps and potential difficulties in M&A could further limit its growth potential.

CVSA has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Adtalem Global Education Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Adtalem Global Education Inc (CVSA) Forecast

Analysts have given CVSA a Buy based on their latest research and market trends.

According to 2 analysts, CVSA has a Buy consensus rating as of Aug 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $155, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $155, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Adtalem Global Education Inc (CVSA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.